Skip to main content

Animations

MJFF Publications

2321 - 2330 of 9145 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • Summary Details
    OPEN
    Title: Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐up
    Journal Name: Brain and Behavior
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/brb3.2257
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contrary
    Journal Name: Brain and Behavior
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/brb3.2220
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Structural network topology and microstructural alterations of the anterior insula associate with cognitive and affective impairment in Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-021-95638-8
    Citation Count: 17
  • Summary Details
    OPEN
    Title: BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ner.13504
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophy
    Journal Name: Clinical Autonomic Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s10286-022-00853-6
    Citation Count: 19
  • Summary Details
    OPEN
    Title: SHIP164 is a chorein motif lipid transfer protein that controls endosome–Golgi membrane traffic
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1083/jcb.202111018
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cells
    Journal Name: FEBS Open Bio
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/2211-5463.13398
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2022.103022
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Australian Parkinson’s Genetics Study (APGS): pilot (n=1532)
    Journal Name: BMJ Open
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1136/bmjopen-2021-052032
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awab431
    Citation Count: 190
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.